Bemærk: Kan ikke leveres før jul.
Forventes på lager: 30-06-2020
Bringing together the expertise of 15 contributors from academia and the industry, this book offers an easy-to-read guide to the various facets of benefit-risk assessment in the major stages of pharmaceutical R&D, from early clinical development to late-stage development to regulatory review to post-launch assessment. Suitable for those in b
| Forlag | Taylor & Francis Ltd |
| Type | Bog |
| Format | Paperback / softback |
| Sprog | Engelsk |
| Udgivelsesdato | 30-06-2020 |
| Første udgivelsesår | 2020 |
| Serie | Chapman & Hall/CRC Biostatistics Series |
| Fagredaktør | Andreas Sashegyi, James Felli, Rebecca Noel |
| Originalsprog | United Kingdom |
| Sideantal | 220 |
| Indbinding | Paperback / softback |
| Forlag | Taylor & Francis Ltd |
| Sideoplysninger | 220 pages |
| Mål | 234 x 156 |
| ISBN-13 / EAN-13 | 9780367576240 |